These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34242482)

  • 1. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Tsan YT; Lee CH; Wang JD; Chen PC
    J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
    Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
    Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study.
    Yun B; Ahn SH; Yoon JH; Kim BK
    Am J Gastroenterol; 2022 May; 117(5):758-768. PubMed ID: 35294425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
    Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
    JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
    Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
    Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
    BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
    Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
    Jang H; Lee YB; Moon H; Chung JW; Nam JY; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Hepatology; 2022 Aug; 76(2):492-501. PubMed ID: 35100447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
    Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
    J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
    El-Serag HB; Johnson ML; Hachem C; Morgana RO
    Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
    Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
    Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case-control study using a nationwide population-based data.
    Cho KS; Sohn W; Lee YC; Chi SA; Cho JY; Kim K; Paik YH
    J Viral Hepat; 2020 Jan; 27(1):68-73. PubMed ID: 31505085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
    Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.